ReviewTherapeutic advances in gastroenterology2017
Current challenges in the treatment of severe
Review in Therapeutic advances in gastroenterology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03895593 (Rescue Fecal Microbiota Transplantation for Refractory Intestinal Infections), which is not on this map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Rescue Fecal Microbiota Transplantation for Refractory Intestinal Infections: China National Registry
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.
- Systematic Review with Meta-Analysis: Fecal Microbiota Transplantation for Severe or Fulminant Clostridioides difficile.Digestive diseases and sciences · 2022Pooled it
- Fecal Microbiota Transplantation for Clostridioides difficile Infection in Immunocompromised Pediatric Patients.Journal of pediatric gastroenterology and nutrition · 2023Article
- Management of Clostridioides difficile infection in adults and challenges in clinical practice: review and comparison of current IDSA/SHEA, ESCMID and ASID guidelines.The Journal of antimicrobial chemotherapy · 2022Review
- Clostridioides difficile infection and One Health: an equine perspective.Environmental microbiology · 2022Review
- Perspectives of traditional Chinese medicine to patch up immune checkpoint blockers.Exploration of targeted anti-tumor therapy · 2022Review
- A species-wide genetic atlas of antimicrobial resistance inMicrobial genomics · 2021Article
- rUTI Resolution After FMT for Clostridioides difficile Infection: A Case Report.Infectious diseases and therapy · 2021Article
- Results from the first English stool bank using faecal microbiota transplant as a medicinal product for the treatment ofEClinicalMedicine · 2020Article
- Efficacy of Fecal Microbiota Transplantation for Clostridium difficile Infection in Children.Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · 2020Article
- Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation.Digestive diseases and sciences · 2020Review
- Faecal microbiota transplant decreases mortality in severe and fulminant Clostridioides difficile infection in critically ill patients.Alimentary pharmacology & therapeutics · 2019Article
- Management of adult Clostridium difficile digestive contaminations: a literature review.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2019Review
- Cost savings following faecal microbiota transplantation for recurrentTherapeutic advances in gastroenterology · 2019Article
- Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2018Article
- Novel FR-900493 Analogues That Inhibit the Outgrowth ofACS omega · 2018Article
- An Updated Review of Clostridium difficile Treatment in Pediatrics.The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAGReview
- Routine Treatment-ResistantCase reports in gastroenterologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fecal microbiota transplantation (FMT) is a very effective treatment for recurrent
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.